8-K: Nordson Corporation Reports Mixed Q3 Results, Updates Full-Year Guidance

Nordson Corporation's third quarter results show a slight revenue increase and adjusted earnings per share above guidance, while updating full-year revenue guidance to include the Atrion acquisition.

Summary

• Nordson Corporation reported third quarter sales of $662 million, a 2% increase year-over-year, which was in line with the midpoint of their guidance.
• The sales increase included a 4% positive impact from acquisitions, offset by a 1% decrease in organic sales and a 1% unfavorable currency translation.
• Adjusted earnings per diluted share were $2.41, which was $0.08 above the midpoint of guidance.
• Net income was $117 million, or $2.04 per diluted share, compared to $128 million, or $2.22 per diluted share, in the prior year's third quarter.
• The company is increasing its full-year revenue guidance to a range of $2,665 million to $2,705 million, reflecting the Atrion acquisition.
• Full-year adjusted earnings per diluted share guidance is maintained at $9.45 to $9.65, inclusive of the slightly dilutive impact of the Atrion acquisition in the fourth quarter.
• EBITDA for the third quarter was $208 million, or 31% of sales, which is flat compared to the prior year's EBITDA of $208 million, or 32% of sales.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the in-line revenue and slightly better than expected adjusted earnings, but tempered by the decrease in net income and some segment weaknesses. The increased full-year revenue guidance is a positive sign, but the dilutive effect of the Atrion acquisition and the overall mixed results prevent a higher score.

Positives

• Sales were in line with expectations, driven by strong organic growth in industrial product lines.
• The Advanced Technology Solutions segment showed sequential growth compared to the second quarter.
• The company delivered strong gross margins and a 31% EBITDA margin.
• Industrial Precision Solutions sales increased by 10% year-over-year.
• The company is increasing full-year revenue guidance.

Negatives

• Organic sales decreased by 1% due to lower demand in electronics and medical product lines.
• Net income decreased to $117 million from $128 million in the prior year's third quarter.
• Adjusted net income decreased to $138 million from $147 million in the prior year.
• Adjusted earnings per diluted share decreased by 6% year-over-year.
• Medical and Fluid Solutions sales decreased by 2% compared to the prior year.
• Advanced Technology Solutions sales decreased by 11% compared to the prior year.

Risks

• The company faces risks related to U.S. and international economic conditions, financial and market conditions, and currency exchange rates.
• There are risks associated with acquisitions, including the ability to successfully integrate them.
• The company is exposed to risks from changes in U.S. trade policy, trade agreements, and tax laws.
• Events beyond the company's control, such as political unrest, acts of terror, natural disasters, and pandemics, pose risks.
• The company's backlog is normalizing and concentrated in systems businesses.

Future Outlook

The company is increasing its full-year revenue guidance to $2,665 million $2,705 million and maintaining full-year adjusted earnings per diluted share guidance at $9.45 $9.65, inclusive of the Atrion acquisition impact.

Management Comments

• We delivered third quarter revenue in line with our expectations, driven by strong organic growth in our industrial product lines.
• Our Advanced Technology Solutions segment sequentially grew compared to second quarter, as order entry steadily improves in electronics end markets.
• Across the company, the teams executed another solid operating performance delivering strong gross margins and 31% EBITDA margin.
• I am pleased with our focus on the customer while managing profitability well against headwinds in select businesses.
• Throughout 2024, we have remained focused on delivering high quality operating performance in a dynamic environment.
• The diversification of our product portfolio, geographic exposure, mix of recurring revenue, in addition to the NBS Next growth framework and the contributions of our recent acquisitions, are positioning us well to end the year in line with record fiscal 2023 revenue.
• I remain pleased with our ability to manage profitability during this period, while remaining invested in the long-term objectives of the business.

Industry Context

Nordson's results reflect a mixed performance across different sectors, with strength in industrial solutions offsetting weakness in electronics and medical. The acquisition of Atrion is expected to boost revenue, while the company is managing profitability amid headwinds in certain businesses.

Comparison to Industry Standards

• Nordson's performance is mixed when compared to other industrial and technology companies.
• Companies like Illinois Tool Works (ITW) and Dover Corporation (DOV) in the industrial sector have shown varying results, with some experiencing similar challenges in specific segments.
• In the technology sector, companies like Applied Materials (AMAT) and Lam Research (LRCX) have also faced fluctuations in demand, particularly in electronics, which aligns with Nordson's experience.
• Nordson's EBITDA margin of 31% is competitive but needs to be compared to specific peers in its segments to determine relative performance.
• The impact of acquisitions on revenue and earnings is a common theme in the industry, and Nordson's integration of Atrion will be closely watched.

Stakeholder Impact

• Shareholders will be impacted by the mixed financial results and updated guidance.
• Employees may be affected by the company's focus on managing profitability and integrating acquisitions.
• Customers may experience changes in product availability and service due to the company's strategic shifts.
• Suppliers may see changes in demand based on the company's performance in different segments.
• Creditors will be interested in the company's ability to manage debt and maintain financial stability.

Next Steps

• Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Thursday, August 22, 2024.
• The company will continue to focus on integrating the Atrion acquisition and managing profitability.

Key Dates

Keywords

Nordson, Financial Results, Earnings, Revenue, Guidance, Acquisition, EBITDA, Industrial Solutions, Medical Solutions, Technology Solutions